126 related articles for article (PubMed ID: 36413827)
1. DNMT3B and TET1 mediated DNA methylation of LATS1 regulates BC progression via hippo signaling pathway.
Wu H; Jiao Y; Guo X; Wu Z; Lv Q
Pathol Res Pract; 2022 Dec; 240():154231. PubMed ID: 36413827
[TBL] [Abstract][Full Text] [Related]
2. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma.
Wu H; Zhang W; Wu Z; Liu Y; Shi Y; Gong J; Shen W; Liu C
Cell Death Dis; 2019 Jan; 10(2):48. PubMed ID: 30718452
[TBL] [Abstract][Full Text] [Related]
3. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q
J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396
[TBL] [Abstract][Full Text] [Related]
4. [High expression of DNMT3B promotes proliferation and invasion of hepatocellular carcinoma cells
Dong G; Qiu F; Liu C; Wu H; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec; 39(12):1443-1452. PubMed ID: 31907153
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HOTAIR promotes the migration and invasion of cervical cancer through DNMT3B/LATS1/ YAP1 pS127 axis.
Zhang Z; Zhou X; Li J; Meng Q; Zheng P
Reprod Biol; 2024 Jun; 24(2):100893. PubMed ID: 38754347
[TBL] [Abstract][Full Text] [Related]
6. Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells.
Xiang YC; Peng P; Liu XW; Jin X; Shen J; Zhang T; Zhang L; Wan F; Ren YL; Yu QQ; Zhao HZ; Si Y; Liu Y
Acta Pharmacol Sin; 2022 Jun; 43(6):1568-1580. PubMed ID: 34522004
[TBL] [Abstract][Full Text] [Related]
7. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
[TBL] [Abstract][Full Text] [Related]
8. S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development.
Hu Y; Zhang R; Lu S; Zhang W; Wang D; Ge Y; Jiang F; Qin X; Liu Y
Int J Biol Sci; 2023; 19(7):2034-2052. PubMed ID: 37151881
[No Abstract] [Full Text] [Related]
9. Epigenetic silencing of TET1 mediated hydroxymethylation of base excision repair pathway during lung carcinogenesis.
Chen HQ; Chen DJ; Li Y; Yuan WB; Fan J; Zhang Z; Han F; Jiang X; Chen JP; Wang DD; Cao J; Liu JY; Liu WB
Environ Pollut; 2021 Jan; 268(Pt B):115860. PubMed ID: 33120142
[TBL] [Abstract][Full Text] [Related]
10. Silence of lncRNA MIAT-mediated inhibition of DLG3 promoter methylation suppresses breast cancer progression via the Hippo signaling pathway.
Li D; Hu X; Yu S; Deng S; Yan M; Sun F; Song J; Tang L
Cell Signal; 2020 Sep; 73():109697. PubMed ID: 32593652
[TBL] [Abstract][Full Text] [Related]
11. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
[TBL] [Abstract][Full Text] [Related]
12. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
[TBL] [Abstract][Full Text] [Related]
13. TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy.
Ren J; Chen X; Li J; Zan Y; Wang S; Tan Y; Ding Y
Epigenetics; 2024 Dec; 19(1):2323751. PubMed ID: 38431880
[TBL] [Abstract][Full Text] [Related]
14. Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner.
García-Gutiérrez L; Fallahi E; Aboud N; Quinn N; Matallanas D
Cell Death Dis; 2022 Aug; 13(8):692. PubMed ID: 35941108
[TBL] [Abstract][Full Text] [Related]
15. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
16. LATS1 K751 acetylation blocks activation of Hippo signalling and switches LATS1 from a tumor suppressor to an oncoprotein.
Yang S; Xu W; Liu C; Jin J; Li X; Jiang Y; Zhang L; Meng X; Zhan J; Zhang H
Sci China Life Sci; 2022 Jan; 65(1):129-141. PubMed ID: 33945069
[TBL] [Abstract][Full Text] [Related]
17. Methylation‑associated inactivation of LATS1 and its effect on demethylation or overexpression on YAP and cell biological function in human renal cell carcinoma.
Chen KH; He J; Wang DL; Cao JJ; Li MC; Zhao XM; Sheng X; Li WB; Liu WJ
Int J Oncol; 2014 Dec; 45(6):2511-21. PubMed ID: 25270913
[TBL] [Abstract][Full Text] [Related]
18. [Under-expression of LATS1 promotes the differentiation, proliferation and migration of mesenchymal stem cells by inhibition the Hippo signaling pathway in vitro].
Li L; Dong L; Hui J; Gao F; Wang Q; Yang L; Zhang J; Yan J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Aug; 29(8):731-737. PubMed ID: 28795673
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of microRNA-103a-3p inhibits the malignancy of thyroid cancer cells through Hippo signaling pathway by upregulating LATS1.
Zhang ML; Sun WH; Wu HQ; Liu ZD; Wang P
Neoplasma; 2020 Nov; 67(6):1266-1278. PubMed ID: 32749848
[TBL] [Abstract][Full Text] [Related]
20. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
